Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geneticure Panel for Hypertension
NCT02988245Phase 2Unknown
- Sponsor
- Geneticure
- Start
- Jun 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by Geneticure. Primary endpoints: Time to Blood Pressure Control at 1 year, Change in Blood Pressure at 1 year and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT02988245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02988245.